Complicated UTI: Symptoms and Treatment
Complicated UTIs present with either systemic symptoms (fever, flank pain, chills, nausea/vomiting) or occur in patients with risk factors such as structural/functional urinary tract abnormalities, immunosuppression, catheters, pregnancy, or male sex. 1
Clinical Presentation
Defining Characteristics
Complicated UTIs are distinguished from simple cystitis by the presence of:
- Systemic symptoms: fever, flank pain (costovertebral angle tenderness), chills, nausea, or vomiting indicating pyelonephritis 1
- Host factors: anatomical abnormalities (obstruction, stones, neurogenic bladder), indwelling catheters, immunocompromised state, diabetes, male sex, or pregnancy 1, 2
Symptom Profile
- Lower tract symptoms: dysuria, urgency, frequency, suprapubic pain, hematuria, new or worsening incontinence 1
- Upper tract symptoms: fever (>38°C), flank pain, costovertebral angle tenderness 1
- Systemic manifestations: rigors, nausea, vomiting, malaise suggesting tissue invasion or bacteremia 2
Important caveat: In older adults, symptoms may be atypical or less clear, requiring careful evaluation of symptom chronicity 1
Diagnostic Approach
Essential Testing
Obtain urine culture and sensitivity BEFORE initiating antibiotics in all complicated UTI cases to guide targeted therapy and document the causative organism 1
Urinalysis findings to integrate with clinical symptoms:
- Pyuria (absence helps rule out infection, but presence has low positive predictive value due to non-infectious inflammation) 1
- Bacteriuria and nitrite positivity 1
- Hematuria 1
Critical principle: Diagnosis should be primarily symptom-based, with urinalysis as supportive evidence—never rely on UA alone 1
When to Image
- Obtain imaging for suspected obstruction, stones, or anatomical abnormalities 1
- Consider upper tract imaging if fever persists beyond 72 hours despite appropriate antibiotics 3
Treatment Algorithm
Empiric Antibiotic Selection
For patients NOT severely ill (no sepsis, able to tolerate oral therapy):
- Levofloxacin 750 mg PO once daily for 5 days is FDA-approved for complicated UTI with demonstrated efficacy 4
- Consider this regimen only if local fluoroquinolone resistance is <10% and patient has not used fluoroquinolones in the last 6 months 5
For severely ill patients or those requiring IV therapy:
- Third-generation cephalosporin (e.g., ceftriaxone) plus gentamicin as first-line empiric therapy 5, 3
- Alternative: amoxicillin plus aminoglycoside, or second-generation cephalosporin plus aminoglycoside 5, 3
For dialysis patients specifically:
- Use IV third-generation cephalosporin or combination therapy as above 5
- Coordinate aminoglycoside dosing with dialysis schedule (administer after dialysis session) 5
- Adjust all doses based on residual renal function 5
Treatment Duration
- Standard duration: 7-14 days depending on clinical response 5, 3
- For men: 14 days when prostatitis cannot be excluded 3
- 5-day levofloxacin regimen acceptable for patients who are not severely ill 4
Tailoring Therapy
Once culture results available:
- Switch to narrow-spectrum agent based on susceptibilities 1
- Use local antibiogram data to guide initial empiric choices 1
- Select agents with minimal impact on normal vaginal and fecal flora to reduce resistance 1
Special Considerations
Urinary Retention Management
If urinary retention is present:
- Perform immediate bladder decompression (postvoid residual >500 mL or >300 mL if symptomatic) 3
- Prefer clean intermittent catheterization over indwelling catheters due to lower infection risk 3
- Use single-use hydrophilic catheters to reduce UTI and hematuria risk 3
- Catheterize every 4-6 hours, keeping volumes <500 mL per collection 3
Monitoring Response
Expect defervescence within 72 hours of appropriate antibiotic therapy 3
If fever persists beyond 72 hours:
- Consider extending treatment duration 3
- Obtain urologic evaluation for obstruction or abscess 3
- Reassess antibiotic choice based on culture results 3
Common Pitfalls to Avoid
- Do not treat asymptomatic bacteriuria unless patient is pregnant, undergoing urologic procedures, or has Proteus colonization 5, 6
- Do not use indwelling catheters when intermittent catheterization is feasible—indwelling catheters have significantly higher infection rates 3
- Do not rely solely on pyuria for diagnosis—it indicates inflammation, not necessarily infection 1
- Avoid nephrotoxic aminoglycosides without careful monitoring and nephrologist coordination, especially in renal impairment 5
- Do not use inadequate treatment duration—this leads to treatment failure and recurrent infections 3
- Avoid broad-spectrum antibiotics when narrow-spectrum options are effective based on culture data to minimize resistance 1